Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1879-1892

  Zhou, Tong ^a   Cheng, Jianhua ^a,b   Yang, Pingar ^a   Wang, Zheng ^a   Liu, Changdan ^a   Su, Xiao ^a   Bluethmann, Horst ^c   Mountz, John D ^a,b  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL MATURATION; CLONAL ANERGY; DNA BINDING; GENE DELETION; GENETIC CODE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; FEMALE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SELF TOLERANCE; SEQUENCE DELETION; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 0029914914     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1879     Document Type: Article

References (75)

1. Nossal, G.J.V. 1994. Negative selection of lymphocytes. Cell. 76:229-239.
2. Golstein, P., D.M. Ojcius, and J.D. Young. 1991. Cell death mechanisms and the immune system. Immunol. Rev. 121:29-65.
3. Cohen, J.J., R.C. Duke, V.A. Fadok, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol 10:267-271.
4. Lucas, B., F. Vasseur, and C. Penit. 1994. Production, selection, and maturation of thymocytes with high surface density of TCR. J. Immunol. 153:53-58.
5. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179:709-713.
6. + thymocytes. J. Immunol. 151:1868-1880.
7. Kappler, J.W., N. Roehm, and P.C. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 149:273-280.
8. a-encoded antigens. Nature (Lond.). 332: 40-45.
9. Berg, L.J., B.F de St. Groth, A.M. Pullen, and M.M. Davis. 1989. Phenotypic differences between αβ versus β T-cell receptor transgenic mice undergoing negative selection. Nature (Lond.). 340:559-562.
10. Burkly, L.C., D. Lo, and R.A. Flavell. 1990. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells. Science (Wash. DC). 248:1364-1368.
11. Ferber, I., G. Schonrich, J. Schenkel, A.L. Mellor, G.J. Hammerling, and B. Arnold. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science (Wash. DC) 263:674-676.
12. Schronrich, G., G. Strauss, K.P. Muller, L. Dustin, D.Y. Loh, N. Auphan, A.M. Schmitt-Verhulst, B. Arnold, and G.J. Hammerling. 1993. Distinct requirement of positive and negative selection for selecting cell type and CDS interaction. J. Immunol. 151:4098-4105.
13. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.). 362:849-852.
14. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.). 362:847-849.
15. Lee, J.M., and A. Bernstein. 1993. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA. 90: 5742-5746.
16. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC.). 267:1449-1456.
17. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
18. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
19. Lynch, D., M. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C.A. Smith, K. Hunter et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
20. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
21. - T cells of lpr mice. J. Exp. Med. 168:2221-2229.
22. + and abnormal lpr and gld cell populations. J. Exp. Med. 170:1869-1877.
23. Mountz, J.D., T.M. Smith, and K.S. Toth. 1990. Altered expression of self-reactive T cell receptor Vβ regions in autoimmune mice. J. Immunol. 144:2159-2166.
24. Zhou, T., H. Bluethmann, J. Eldridge, K. Berry, and J.D. Mountz. 1991. Abnormal thymocyte development and production of autoreactive T cells in TCR transgenic autoimmune mice. J. Immunol. 147:466-474.
25. Zhou, T., J.D. Mountz, C.K. Edwards III, K. Berry, and H. Bluethmann. 1992. Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr. J. Exp. Med. 176: 1063-1072.
26. Bissonnette, R.P., F. Echeverri, A. Mahboubi, and D.R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (Lond.). 359:552-554.
27. Fanidi, A., E.A. Harrington, and G.I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (Lond.). 359:554-556.
28. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
29. Moore, N.C., G. Anderson, G.T. Williams, and J.J. Owen. 1994. Developmental regulation of bcl-2 expression in the thymus. Immunology. 81:115-119.
30. Veis, D., C.M. Sorenson, J.R. Shutter, and S.J. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:229-240.
31. Katsumata, M., R.M. Siegel, D.C. Louie, T. Miyashita, Y. Tsujimoto, P.C. Nowell, M.I. Greene, and J.C. Reed. 1992. Differential effects of bcl-2 on T and B cells in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:11376-11380.
32. Siegel, R.M., M. Katsumata, T. Miyashita, D.C. Louie, M.I. Greene, and J.C. Reed. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. USA. 89:7003-7007.
33. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagawa, and S. Korsmeyer. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:879-888.
34. Strasser, A., A.W. Harris, H. von Boehmer, and S. Cory. 1994. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a Bcl-2 transgene. Proc. Natl. Acad. Sci. USA. 91:1376-1380.
35. Lundberg, K., and K. Shortman. 1994. Small cortical thymocytes are subject to positive selection. J. Exp. Med. 179: 1475-1483.
36. + thymocytes is altered by overexpression of the bcl-2 protooncogene in the thymus. J. Exp. Med. 179:145-153.
37. Milbrandt, J. 1988. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1: 183-195.
38. Hazel, T.G., D. Nathans, and L.F. Lau. 1988. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl. Acad. Sci. USA. 85:8444-8448.
39. Williams, G.T., and L.F. Lau. 1993. Activation of the inducible orphan receptor gene Nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol. Cell. Biol. 13:6124-6136.
40. Abu-Shakra, S.R., A.J. Cole, and D.B. Drachman. 1993. Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle. Brain Res. Rev. 18:216-220.
41. Law, S.W., O.M. Conneely, F.J. DeMayo, and B.W. O'Malley. 1992. Identification of a new brain-specific transcription factor, NurR1. Mol. Endocrinol. 6:2129-2135.
42. Davis, I.J., T.G. Hazel, R.H. Chen, J. Blenis, and L.F. Lau. 1993. Functional domains and phosphorylation of the orphan receptor Nur77. Mol. Endocrinol. 7:953-964.
43. Yoon, J.K., and L.F. Lau. 1993. Transcriptional activation of the inducible nuclear receptor gene Nur77 by nerve growth factor and membrane depolarization in PC12 cells. J. Biol. Chem. 268:9148-9155.
44. Wilson, T.E., T.J. Fahrner, M. Johnston, and J. Milbrandt. 1991. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (Wash. DC). 252:1296-1300.
45. Wilson, T.E., R.E. Paulsen, K.A. Padgett, and J. Milbrandt. 1992. Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science (Wash. DC). 256:107-110.
46. Wilson, T.E., T.J. Fahmer, and J. Milbrandt. 1993. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 13:5794-5804.
47. Wilson, T.E., K.A. Padgett, M. Johnston, and J. Milbrandt. 1993. A genetic method for defining DNA-binding domains: application to the nuclear receptor NGFI-B. Proc. Natl. Acad. Sci. USA. 90:9186-9190.
48. Liu, Z.-G., S.W. Smith, K.A. McLaughlin, L.M. Schwartz, and B.A. Osborne. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene Nur77. Nature (Lond.). 367:281-284.
49. Woronica, J.D., B. Cainan, V. Ngo, and A. Winoto. 1994. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature (Lond.). 367:277-280.
50. Okabe, T., R. Takayanagi, K. Imasaki, H. Masafumi, H. Nawata, and T. Watanabe. 1995. cDNA cloning of a NGF1-B/ Nur77-related transcription factor from an apoptotic human T cell line. J. Immunol. 154:3871-3879.
51. Lee, S.L., R.L. Wesselschmidt, G.P. Linette, O. Kanagawa, J.H. Russell, and J. Milbrandt. 1995. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B Nur77. Science (Wash. DC). 269:532-535.
52. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature (Lond.). 341:746-749.
53. Kaye, J., and S.M. Hedrick. 1988. Analysis of specificity for antigen, Mls, and allogeneic MHC by transfer of T-cell receptor α- and β-chain genes. Nature (Lond.). 336:580-583.
54. + T cells in lpr/lpr mice. J. Exp. Med. 172:1805-1817.
55. Deryckere, F., and F. Gannon. 1994. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 16:405-409.
56. Garner, M., and A. Revzin. 1982. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9: 3047-3059.
57. Cheng, J., T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, P.J. Barr, and J.D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the fas molecule. Science (Wash. DC). 263:1759-1762.
58. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
59. + T cells in MRL-lpr/lpr mice. Clues from a T cell receptor β transgenic mouse. J. Immunol. 150:3651-3667.
60. + thymocytes. Nature (Lond.). 333:742-745.
61. Kisielow, P., H.S. Teh, H. Bluethmann, and H. von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature (Lond.). 335: 730-734.
62. von Boehmer, H. 1990. Developmental biology of T cells in T cell receptor transgenic mice. Annu. Rev. Immunol. 8:531-555.
63. Teh, H.-S., H. Kishi, B. Scott, and H. von Boehmer. 1989. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169:795-806.
64. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373:444-448.
65. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, and C.F. Ware. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
66. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocnne T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373:438-441.
67. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
68. Kiefer, M.C., M.J. Brauer, V.C. Powers, J.J. Wu, S.R. Umansky, L.D. Tomei, and P.J. Barr. 1995. Modulation of apoptosis by the widely distributed bcl-2 homologue Bak. Nature (Lond.). 374:736-739.
69. Yang, E., J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer. 1995. Bad, a heterodimeric partner for BelXL and Bcl-2, displaces Bax and promotes cell death. Cell. 80: 285-291.
70. Yin, X.M., Z.N. Oltval, and S.J. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (Lond.). 369:321-323.
71. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609-619.
72. Yang, Y., M. Mercep, C.F. Ware, and J.D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673-1682.
73. Vacchio, M.S., V. Papadopoulos, and J.D. Ashwell. 1994. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179:1835-1846.
74. Kabelitz, D., T. Pohl, and K. Pechhold. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today. 14:339-340.
75. Green, D.R., and D.W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476-487.